Orphazyme
No bio yet
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Orphazyme
Danish biopharma company, listed on Nasdaq Copenhagen, with a late-stage drug pipeline, developing new treatment options for orphan protein-misfolding diseases.